Contact

The Visionaries Behind Sound Science.®

Meet the people who are transforming practices just like yours.

Visionaries Anchors

Management

Senior management has more than 100 years combined operating experience and customer insight. This includes key personnel in science, engineering and management with demonstrated success in commercializing new medical products. A summary of the key company management:

Sonendo Bjarne Bergheim
Bjarne Bergheim
President & CEO

Bjarne brings more than 15 years of experience driving and leading disruptive innovation in life science companies. Prior to Sonendo®, Bjarne was a member of the Fjord Ventures, LLC team involved in the selection and due-diligence of portfolio companies. From 1998 to 2006, Bjarne was responsible for developing the first trans-apical valve procedure at 3F Therapeutics, Inc. Mr. Bergheim has been President and CEO of Sonendo, Inc. since 2008. He graduated Cum Laude with a Bachelor of Science degree in Mechanical Engineering from the University of California, Irvine in 1997 and earned a Master of Science degree from the California Institute of Technology in 1998.

Sonendo Chris Rabbitt
Chris Rabbitt
Chief Commercial Officer

Chris brings nearly 20 years of experience in sales and marketing within the medical device industry. Prior to joining Sonendo, Chris spent over 12 years at Intuitive Surgical, Inc., the leader in surgical robotics, in positions of increasing responsibility including Director, Global Sales and Marketing, Cardiothoracic Surgery. Prior to Intuitive, Chris spent 7 years at Ethicon, Inc. / CardioVations, a division of Johnson and Johnson, driving the development of minimally invasive cardiac surgery in various sales, sales management and marketing roles. Chris holds a BA in Political Economics from the University of California at Berkeley and a post-baccalaureate BS in pre-medical sciences from San Francisco State University.

Jack Glenn - Chief Financial Officer
Jack Glenn
Chief Financial Officer

Jack brings more than 25 years of leadership experience within public and private companies in the life science industry. Jack most recently served as Chief Financial Officer at Armetheon, a privately held, specialty pharmaceutical company. Prior to Armetheon, Jack served as Chief Financial Officer of Solta Medical, a publicly traded aesthetic device company sold to Valeant Pharmaceutical. Prior to Solta Medical, Jack held the role of Chief Financial Officer at Cholestech, a publicly traded company providing diagnostic tools for the monitoring and assessment of heart disease. Cholestech was sold to Inverness Medical Innovations.  Prior to Cholestech, Jack held the role of Chief Financial Officer for Invivo Corporation. Invivo Corporation, a publicly traded medical device manufacturer, was sold to Intermagnetics. Jack holds a BS in business administration from the University of Nevada and an MBA from Santa Clara University.

Sonendo Bob Anthony
Bob Anthony
Vice President, Operations

Bob has more than 25 years of start-up and established company operations management experience including 17 years at Guidant Corporation before the sale of the company to Abbott Laboratories. While at Guidant, Bob lead the development and growth of the operations organizations for the Cardiovascular and Endovascular Solutions business units. Most recently, Bob was the Vice President of Supply Chain at Masimo Corporation.

Sonendo Bob Guyatt
Bob Guyatt
Vice President, Marketing

Bob has more than 25 years of experience in sales and marketing roles. Most recently, prior to joining Sonendo, Bob spent the last five years with Danaher in key VP of Marketing roles for operating companies within their dental platform. In addition, Bob was recruited to lead the re-positioning strategy for Lifecore Biomedical which, two years later, resulted in the sale of the company at a significant per share premium. Bob has worked in sales and marketing roles at various organizations such as the Gallo Wine Company, where he started his sales and marketing career.

Sonendo Dan Miller
Dan Miller
Senior Vice President, Regulatory Affairs, Clinical Affairs and Quality Assurance

Dan has more than 25 years of experience in regulatory and clinical affairs and quality assurance, most recently as the Vice President of Regulatory Affairs, Clinical Affairs & Quality Assurance at Integra Life Sciences, a medical device company based in Vista, CA; and Senior Director of Regulatory/Clinical Affairs and Quality at ROX Medical, a medical device company based in San Clemente, CA.

Sonendo Mehrzad Khakpour, PhD
Mehrzad Khakpour, PhD
Vice President, Research & Development

Mehrzad joined Sonendo in 2008, and has been the primary research and innovation driver of the Sonendo technology. In addition to developing the GentleWave® Procedure, he also has primary responsibility for new product development focusing on consumables. During his career, Mehrzad has authored numerous patent applications and professional journal articles.

Sonendo Kristy Miller
Kristy Miller
Head of Human Resources

Kristy has more than 20 years of experience as a human resources professional. She has held senior human resources roles in start-up and Fortune 500 organizations across various industries which include Semiconductor, Defense and Education Services. Most recently, she served as the Director of Human Resources for Experian, an information services company that provides data and analytical tools to business and organizations worldwide. Kristy holds a MBA from the University of La Verne and a Bachelor of Arts in Business Administration from California State University, Fullerton.

Board of Directors

Sonendo Bjarne Bergheim
Bjarne Bergheim
President & CEO

Bjarne brings more than 15 years of experience driving and leading disruptive innovation in life science companies. Prior to Sonendo®, Bjarne was a member of the Fjord Ventures, LLC team involved in the selection and due-diligence of portfolio companies. From 1998 to 2006, Bjarne was responsible for developing the first trans-apical valve procedure at 3F Therapeutics, Inc. Mr. Bergheim has been President and CEO of Sonendo, Inc. since 2008. He graduated Cum Laude with a Bachelor of Science degree in Mechanical Engineering from the University of California, Irvine in 1997 and earned a Master of Science degree from the California Institute of Technology in 1998.

Erik Amble Sonendo
Erik Amble
Director

Erik Amble has extensive venture capital investing experience, including the last 15 years in the healthare and life science industries. He is currently managing partner at NeoMed, an international venture capital company he founded. Mr. Amble previously co-founded and was chairman of the Norwegian Venture Capital Association. He has served as board member of Clavis Pharma AS, Genovision AS, Thommen Medical AG and Vessix Vascular Inc. He is currently a board member of Sequana Medical AG and JenaValve Inc. Mr. Amble earned a PhD in organic chemistry from the University of Oslo and a Master of Science degree in Management from the Graduate School of Business, Stanford University.

Sonendo Olav Bergheim
Olav Bergheim
Director

Olav Bergheim has over 30 years of experience in creating and managing life science companies. He is a founder of Sonendo, Inc., in addition to several other successful life science companies including Volcano Corporation, 3F Therapeutics (acquired by Medtronic), Glaukos Corporation, Lonestar Heart Inc., Prelude Corporation and Metronom Health, Inc. Mr. Bergheim is also the founder of Fjord Ventures LLC, a life science accelerator located in Laguna Hills, California, where Sonendo was created. Mr. Bergheim was the chairman of Vessix Vascular, Inc. (acquired by Boston Scientific). Prior to starting Fjord Ventures, he spent 10 years at Domain Associates as a company creator and general partner. Prior to Domain, Mr. Bergheim spent 18 years with Baxter Healthcare at US and international locations, where he held various leadership and operating roles. Mr. Bergheim was a Corporate VP of Baxter as well as President of Baxter Germany, President of Baxter’s Cardiovascular Group (now Edwards Life Sciences) and General Manager of the Nordic area.

Sonendo Vince Burgess
Vince Burgess
Director

Vince Burgess has more than 20 years of experience in healthcare operations, business development and venture capital investment. He is currently a Venture Partner with OrbiMed. Mr. Burgess was on the initial executive team at Volcano Corp., where he was Group President, Advanced Imaging Systems, and also led global marketing and business development from 2002 to 2010. At Volcano, he was a key architect of the company’s product, marketing and M&A/partnering strategies. During his tenure, Volcano grew from a start-up to a global company with more than 1,000 employees and a market capitalization of more than $1.2 billion. Previously, Mr. Burgess served as a general partner of San Diego-based Sorrento Ventures, focusing on the firm’s healthcare investments. Mr. Burgess earned his Master of Business Administration degree at the Anderson School at UCLA and his Bachelor of Science degree in Business Administration from USC.

Sonendo Thomas R. Engels
Thomas R. Engels
Director

Thomas Engels is a retired executive of 3M Corporation, having worked in various assignments spanning a 39-year career with the company, including 15 years in executive business management. Prior to retiring from 3M, he served as vice president for the 3M ESPE Dental Division for six years, where he led the division globally with a progressive strategy of new product innovation and acquisitions. Other executive management assignments for 3M included managing director of 3M’s Mexico subsidiary and vice president/general manager of the Medical Device Division. The majority of his career was spent in various R&D, manufacturing and business management assignments spanning a wide range of medical supply, medical device and dental businesses. He has held various board positions including with Minnesota-based Medical Alley, the Mexico American Chamber of Commerce and the Dental Trade Alliance. He is currently an active board member of the National Children’s Oral Health Foundation. Mr. Engels pursued undergraduate studies at St. John’s University in Minnesota, prior to transferring to the University of Minnesota’s Institute of Technology, where he received a Bachelor of Science degree in Mechanical Engineering.

Sonendo Dan Even
Dan Even
Director

Dan Even spent more than 30 years in progressive leadership roles with Sybron Dental Specialties, including president from 2006-2011. While under his leadership, Sybron surpassed $1 billion in revenue with a broad portfolio of successful platforms including orthodontics (Ormco), endodontics (Sybron Endo), implants (Implant Direct), surface disinfection (Metrex) and esthetic restorative products (Kerr). Mr. Even has led several technological advancements in the field of dentistry, both by leading strategic acquisition activity as well as organically cultivating and optimizing internal development teams. He is a member and past president of the National Children’s Oral Health Foundation, and a past board member and president of the Orthodontic Manufacturing Association, as well as the American Association of Orthodontics Foundation. Mr. Even earned his Master of Business Administration degree at California Polytechnic University, Pomona, and a Bachelor of Science degree in Economics from the University of California, Davis.

Sonendo Paul Madera
Paul Madera
Director

Paul Madera is Managing Director of Meritech Capital Partners, a $3 Billion venture capital fund he co-founded in 1999. Over the years he has led Meritech’s investments into several notable tech companies including 2Wire, BlueArc, Facebook, IntraLase, Riverbed Technology, Salesforce.com and Yammer. Prior to Meritech, he was an investment banker with Montgomery Securities and Morgan Stanley, and he served in the US Air Force as an F-16 Instructor Pilot. He holds a BS from the US Air Force Academy, and an MBA from The Stanford Graduate School of Business.

Sonendo Frank Yu
Frank Yu
Director

Mr. Yu is Co-founder and CEO of Themes Investment Partners, a China-focused private equity fund, and Founder and CEO of Ally Bridge Group, a global healthcare-focused investment fund. Mr. Yu has expertise in cementing strategic partnerships between leading players in China and global companies with cutting-edge technologies, as well as helping global companies to open the China market. In addition to Sonendo, Mr. Yu has led and actively manages investments in medtech companies including Lifetech Scientific (Medtronic’s strategic partner in China), LoneStar Heart, Metronom and Broncus Medical, and bio-pharmaceutical companies including China Animal Health (Eli Lilly-Elanco’s strategic partner in China), Apexigen, Kato and ImmunGene. Previously, Mr. Yu was Managing Director and Head of China Investments at Och-Ziff Capital Management, a leading global hedge fund. Prior to Och-Ziff, Mr. Yu was a Managing Director at Goldman Sachs Hong Kong, where he had played instrumental roles in some of the most important restructuring, IPO and M&A transactions of leading Chinese companies, and had advised leading global institutions on their China and Asia strategies and transactions. Before Goldman Sachs, Mr. Yu had worked at Moody’s in New York and then Credit Suisse in London and Hong Kong.

Michael Zhao
Michael Zhao
Co-Director

Mr. Michael Zhao is CEO of DiNovA Medtech, specializing in investing in and bringing innovative medical technologies to China, including Vessix, LoneStar, Broncus and Venus. Prior to that, Michael was the Executive Director and CEO of Lifetech Scientific. During his tenure (2010-15), the company went public in Hong Kong with an enhanced valuation of up to 40 folds due to his vision to lead and orchestrate a strategic partnership between Lifetech and Medtronic that became a global benchmark for international collaboration. Michael started his career in medical device with Johnson & Johnson’s Cordis division in 1998, and took on global leadership positions of increasing responsibility, including Global Product Strategy (USA), European Product Manager (Belgium), Group Marketing Manager (Australia & New Zealand) and General Manager (China). 

Michael is an active contributing member to China’s healthcare industry. He is co-founder and co-chairman of the China Innovation in Cardiology conference (CIC); co-Director of the CV Engineering Center of Jiang Su Provincial Hospital and executive member of the Society of Pediatric Cardiology, Pacing &EP Society, Biomaterials Society and the Association of Medical Device Industry. He is also an active board member of seven medical device companies. 

Michael has a BSc degree from Huntington College (USA), MBA from the University of Western Ontario (Canada) and studied at Leeds University (England) and Fudan University (Shanghai).

THE GENTLEWAVE® SYSTEM CAN SET YOUR PRACTICE APART. contact us today to find out more.

Required Wrapper

* Required fields

By submitting your request, you agree to receive future communications from Sonendo, Inc.

Thank you for your submission.
A representative will be in touch with you shortly!

Please ensure all fields have valid entries before submitting form